Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Annaly Capital Management
NLY
$17.4B
| $174M | 0.22% |
3,601,372
+1,005,240
| +39% | +$47.4M |
|
77
FirstEnergy
FE
$27.1B
| $173M | 0.22% |
5,934,000
-175,108
| -3% | -$5.2M |
|
78
Analog Devices
ADI
$188B
| $172M | 0.22% |
2,207,893
+94,804
| +4% | +$7.53M |
|
|
CHL
79
DELISTED
China Mobile Limited
CHL
| $169M | 0.22% |
3,192,500
+341,000
| +12% | +$18.5M |
|
80
Fortinet
FTNT
$119B
| $169M | 0.22% |
22,608,500
+3,631,500
| +19% | +$28.1M |
|
81
Honeywell
HON
$72.9B
| $169M | 0.22% |
1,404,889
+896,556
| +176% | +$106M |
|
82
WIX.com
WIX
$2.79B
| $168M | 0.21% |
2,414,400
+462,700
| +24% | +$34.6M |
|
83
McKesson
MCK
$105B
| $165M | 0.21% |
+1,000,900
| New | +$152M |
|
84
McDonald's
MCD
$194B
| $164M | 0.21% |
1,072,700
-205,100
| -16% | -$29.6M |
|
85
Markel Group
MKL
$22.8B
| $164M | 0.21% |
167,577
+12,296
| +8% | +$11.9M |
|
86
Elevance Health
ELV
$84.7B
| $163M | 0.21% |
867,200
-368,400
| -30% | -$66.2M |
|
87
Vodafone
VOD
$36.7B
| $162M | 0.21% |
5,641,400
+467,200
| +9% | +$13M |
|
88
Kinder Morgan
KMI
$70.1B
| $157M | 0.2% |
8,210,372
+4,694,441
| +134% | +$93.3M |
|
89
General Mills
GIS
$20.2B
| $157M | 0.2% |
2,831,500
+827,200
| +41% | +$47.2M |
|
90
Allegiant Air
ALGT
$2.37B
| $154M | 0.2% |
1,135,500
-52,100
| -4% | -$7.63M |
|
91
Procter & Gamble
PG
$338B
| $153M | 0.2% |
1,761,229
+1,446,429
| +459% | +$127M |
|
|
WCG
92
DELISTED
Wellcare Health Plans, Inc.
WCG
| $153M | 0.2% |
851,293
+232,993
| +38% | +$38.6M |
|
93
Enbridge
ENB
$113B
| $153M | 0.19% |
3,832,082
-2,290,900
| -37% | -$92.2M |
|
|
PF
94
DELISTED
Pinnacle Foods, Inc.
PF
| $152M | 0.19% |
2,559,700
+1,021,200
| +66% | +$61M |
|
|
CELG
95
DELISTED
Celgene Corp
CELG
| $152M | 0.19% |
1,170,638
+1,038,500
| +786% | +$127M |
|
|
JNPR
96
DELISTED
Juniper Networks
JNPR
| $151M | 0.19% |
5,427,091
+3,604,200
| +198% | +$105M |
|
|
VGR
97
DELISTED
Vector Group Ltd.
VGR
| $151M | 0.19% |
11,531,534
-780,379
| -6% | -$10.3M |
|
98
Petrobras
PBR
$116B
| $150M | 0.19% |
18,753,988
+9,046,753
| +93% | +$80.7M |
|
99
Mondelez International
MDLZ
$78.9B
| $148M | 0.19% |
3,427,498
-1,146,100
| -25% | -$51.7M |
|
100
Berkshire Hathaway Class A
BRK.A
$1.11T
| $147M | 0.19% |
579
+72
| +14% | +$18M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.